Cutler Group’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-700
| Closed | -$2K | – | 2096 |
|
|
2022
Q4 | $2K | Sell |
700
-598
| -46% | -$1.71K | ﹤0.01% | 1573 |
|
|
2022
Q3 | $6K | Buy |
+1,298
| New | +$6K | ﹤0.01% | 1517 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2402 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2496 |
|
|
2019
Q1 | – | Sell |
-1,256
| Closed | -$14K | – | 2103 |
|
|
2018
Q4 | $14K | Hold |
1,256
| – | – | ﹤0.01% | 1186 |
|
|
2018
Q3 | $21K | Hold |
1,256
| – | – | ﹤0.01% | 1158 |
|
|
2018
Q2 | $17K | Hold |
1,256
| – | – | ﹤0.01% | 1175 |
|
|
2018
Q1 | $23K | Buy |
+1,256
| New | +$23K | ﹤0.01% | 1156 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 2747 |
|
|
2017
Q3 | – | Sell |
-3,900
| Closed | -$34K | – | 3023 |
|
|
2017
Q2 | $34K | Buy |
3,900
+3,100
| +388% | +$27K | ﹤0.01% | 1641 |
|
|
2017
Q1 | $4K | Sell |
800
-1,693
| -68% | -$8.47K | ﹤0.01% | 2471 |
|
|
2016
Q4 | $7K | Sell |
2,493
-3,900
| -61% | -$11K | ﹤0.01% | 2391 |
|
|
2016
Q3 | $29K | Sell |
6,393
-34,630
| -84% | -$157K | ﹤0.01% | 1691 |
|
|
2016
Q2 | $237K | Buy |
41,023
+29,807
| +266% | +$172K | 0.01% | 617 |
|
|
2016
Q1 | $67K | Sell |
11,216
-49,400
| -81% | -$295K | ﹤0.01% | 1144 |
|
|
2015
Q4 | $553K | Buy |
+60,616
| New | +$553K | 0.03% | 356 |
|